A Randomized Phase I Study Comparing the Pharmacokinetics of HD201, a Trastuzumab Biosimilar, With European Union-sourced Herceptin

Pivot, X; Deslypere, JP; Park, LS; Kim, MJ; Lee, W; Lee, J

Pivot, X (reprint author), Paul Strauss Canc Ctr, 3 Rue Porte Hop BP 30042, F-67065 Strasbourg, France.

CLINICAL THERAPEUTICS, 2018; 40 (3): 396

Abstract

Purpose: This first-in-human study of HD201 was designed to evaluate the pharmacokinetic (PK) equivalence between this biosimilar candidate and trastu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索